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Erythrocytes regulate vascular function through the modulation of oxygen delivery and
the scavenging and generation of nitric oxide (NO). First, hemoglobin inside the red
blood cell binds oxygen in the lungs and delivers it to tissues throughout the body in
an allosterically regulated process, modulated by oxygen, carbon dioxide and proton
concentrations. The vasculature responds to low oxygen tensions through vasodilation,
further recruiting blood flow and oxygen carrying erythrocytes. Research has shown
multiple mechanisms are at play in this classical hypoxic vasodilatory response, with a
potential role of red cell derived vasodilatory molecules, such as nitrite derived nitric oxide
and red blood cell ATP, considered in the last 20 years. According to these hypotheses,
red blood cells release vasodilatory molecules under low oxygen pressures. Candidate
molecules released by erythrocytes and responsible for hypoxic vasodilation are nitric
oxide, adenosine triphosphate and S-nitrosothiols. Our research group has characterized
the biochemistry and physiological effects of the electron and proton transfer reactions
from hemoglobin and other ferrous heme globins with nitrite to form NO. In addition
to NO generation from nitrite during deoxygenation, hemoglobin has a high affinity for
NO. Scavenging of NO by hemoglobin can cause vasoconstriction, which is greatly
enhanced by cell free hemoglobin outside of the red cell. Therefore, compartmentalization
of hemoglobin inside red blood cells and localization of red blood cells in the blood
stream are important for healthy vascular function. Conditions where erythrocyte lysis
leads to cell free hemoglobin or where erythrocytes adhere to the endothelium can result
in hypertension and vaso constriction. These studies support a model where hemoglobin
serves as an oxido-reductase, inhibiting NO and promoting higher vessel tone when
oxygenated and reducing nitrite to form NO and vasodilate when deoxygenated.
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How erythrocytes modulate vascular tone has been widely studied over the last two decades. The
vasodilation of the vasculature under hypoxic conditions has inspired much research ranging from
the effect of oxygen partial pressure on smooth muscle cell contractility and endothelial nitric
oxide synthase (eNOS) activity to nitrite reduction by hemoglobin (Hb) inside erythrocytes and
subsequent production of nitric oxide (Figure 1). Here we review how red blood cells (RBCs) and
hemoglobin regulate vascular function and blood flow.
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FIGURE 1 | RBCs function as a transporter of oxygen from the lungs to the tissue and help establish hemostasis and vascular function. Since Hb inside RBCs is a
very effective scavenger of NO, a vasodilator produced by the endothelium (brown), mechanism such as a cell free zone created by fluid dynamics, RBC membrane
and internal diffusion minimize NO scavenging. In diseases where hemolysis and RBC adhesion occur these mechanisms to minimize NO scavenging are
compromised and vasoconstriction occurs. However, in addition to scavenging NO data supports a role of deoxygenated RBCs in the production of NO leading to
vasodilation under hypoxic conditions.
OXYGEN DELIVERY
Many biochemistry texts provide thorough descriptions of the
basic mechanisms of oxygen delivery by hemoglobin. Therefore,
we will limit our discussion to a brief introduction. The
hemoglobin molecule is a heterotetramer of hemoglobin alpha-
beta dimers. Under high oxygen tension, eachmonomer can bind
an O2 molecule. As hemoglobin binds oxygen, conformational
changes occur to the protein and the binding affinity of
the protein for molecular oxygen increases. Thus, binding is
cooperative so that binding subsequent molecules of oxygen
becomes easier after initial binding. Cooperative binding can be
understood by a two-state model: The high affinity R-state and
the low affinity T-state (Monod et al., 1965; Eaton et al., 1999).
When hemoglobin has one or less oxygen molecules bound it
is virtually always in the tense T-state. When it has 3–4 oxygen
molecules bound it is virtually always in the R-state. Once 2 or
more oxygen bind to a hemoglobin molecule that has no oxygen
it will undergo a conformational change to the R-state where its
oxygen affinity is now higher and it binds more oxygen. This
homotropic regulation leads to a sigmoidal curve of hemoglobin
fractional saturation vs. partial pressure of oxygen and allows
hemoglobin to function as an efficient transporter of oxygen from
the lungs to the tissues.
The complexity of oxygen delivery goes beyond the
homotropic regulation. The pH of the blood also effects
oxygen binding. The Bohr Effect, reported in the early 1900’s,
describes how increased acidity which occurs at low oxygen
tension leads to protonation and stabilization of the T-state of
hemoglobin promoting oxygen release. Additionally, carbon
dioxide and 2,3-bisphosphate also act as heterotropic regulators,
both decreasing the affinity of Hb for oxygen.
Therefore, RBCs contribute to vascular function through the
delivery of oxygen by hemoglobin.
One mechanism through which oxygen tension and therefore
RBCs effect vascular function is the contractile force of smooth
muscle cells. Chang and Detar reported that a reduction in
oxygen pressure led to a reduced contractile tension of helical
strips cut from aorta, femoral arteries and small arteries from
skeletal muscle (Chang and Detar, 1980). Additionally Taggart et
al saw a decrease in smooth muscle force in hypoxia indicating
smoothmuscle response to oxygenmay be independent of factors
from the endothelium (Taggart and Wray, 1998). Potential
mechanics of smooth muscle response to oxygen tension are
increased ATP-sensitive K+ efflux or decreased voltage-sensitive
Ca+2 influx (Franco-Obregón et al., 1995; Taggart and Wray,
1998). These effects have been recently reviewed (Jackson, 2016).
Alternatively, low oxygen tension effects the endothelial
production of nitric oxide (NO) by eNOS, which requires
oxygen as a substrate along with L-arginine (Palmer and
Moncada, 1989; Kwon et al., 1990). Many researchers have shown
diminished relaxation by endothelial cells under low oxygen
tension (Furchgott and Zawadzki, 1980; De Mey and Vanhoutte,
1983; Lieberthal et al., 1989). Specifically, the apparent Km of
eNOS for O2 is 4µM and NOS activity begins to slow down once
oxygen tensions starts falling below 1% (7.6 torr or 10µM) (Abu-
Soud et al., 2000; van Faassen et al., 2009). In summary, through
the management of oxygen delivery RBCs effect eNOS function
and smooth muscle contractility.
COMPARTMENTALIZATION AND
LOCALIZATION OF HEMOGLOBIN
In addition to oxygen delivery, hemoglobin affects vascular
function as a strong scavenger of NO. Furchgott and coworkers
discovered that there is an agent produced in the endothelium
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that relaxes blood vessels, the endothelium relaxation factor
(EDRF) (Furchgott and Zawadzki, 1980). The EDRF was then
identified as NO (Ignarro et al., 1987; Palmer et al., 1987) that
acts via activation of soluble guanylyl cyclase (Arnold et al., 1977).
Endothelial nitric oxide synthase located on endothelial cell
membranes produces NO that binds to soluble guanylyl cyclase
in smooth muscles cells triggering a cell-signaling cascade that
results in vasodilation. Chu et al. demonstrated the physiological
regulation of blood flow and vasomotion by endogenously
produced NO in awake dogs (Chu et al., 1991) and Quyyumi
et al. showed atherosclerosis risk factors altered the response
of coronary arteries to diminished NO production (Quyyumi
et al., 1995). Additionally, NO has the anti-thrombotic effect
of diminishing platelet activation (Schafer et al., 1980) and
the anti-inflammatory effect of inhibiting leukocyte adhesion
to the endothelium (Kubes et al., 1991). NO also leads to
indirect vasodilation by inhibiting sympathetic vasoconstriction
(Zanzinger et al., 1994). This is only a very small selection of
a strong body of work that displays the role of NO in vascular
function, which has been recently reviewed (Lundberg et al.,
2015).
Since hemoglobin is present in the blood at a concentration
of 10mM in heme and ferrous heme has a strong affinity for NO
with a dissociation constant of KD 10
−10 to 10−11 M (Cooper,
1999), and the association rate constant is 107-108 M−1s−1
(Cassoly and Gibson, 1975), you might expect there to be no free
NO at all.
HbFe(II)+NO
fast
slow
HbFe(II)NO. (1)
Moreover, oxygenated hemoglobin reacts with NO to form
nitrate (dioxygenation of NO) extremely fast (6–8 × 108
M−1s−1) (Doyle and Hoekstra, 1981; Eich et al., 1996; Herold
et al., 2001) inactivating the NO, so that calculations predict that
NO could not act as the EDRF (Lancaster, 1994; Vaughn et al.,
1998).
HbFe(II)O2 +NO→ HbFe(III)+NO
−
3 . (2)
However, as demonstrated above in the work by Chu et al.
endothelial NO does play a physiological role in vascular function
(Chu et al., 1991).
One can explain this paradox of NO bioavailability and Hb
concentration in the blood by considering Hb encapsulation
by RBCs. Experiments where RBCs are mixed with NO in
suspension or in a stopped flow apparatus show that RBCs
scavengeNO 1,000 times slower than cell-freeHb (Liu et al., 1998;
Vaughn et al., 2000). Researchers have attributed this change in
the rate of scavenging to a few mechanisms. One mechanism is
the diffusion of NO to the RBC, which contributes to an unstirred
layer around the cell (Coin andOlson, 1979; Liu et al., 1998, 2002;
Azarov et al., 2005). A second mechanism is the membrane of
the RBC acting as a barrier to diffusion (Vaughn et al., 2000;
Huang et al., 2001, 2007). Third is diffusion of NO inside the
RBC (Vaughn et al., 2000; Sakai et al., 2008). Our work suggests
that rate limitations due to diffusion to the RBC are predominant
(Azarov et al., 2005, 2011).
In addition to these changes under static conditions, a cell
free zone created by the fluid dynamics of blood flow further
reduces NO scavenging. The velocity of blood near the vessel
wall is slower than in the center of the vessel due to friction. This
creates a pressure gradient that pushes RBCs toward the center of
the vessel away from the NO producing endothelium. Bugliarello
and Sevilla, Cokelet and Liao et al. experimentally showed the
presence of a cell free zone and computationalmodeling by Butler
et al. supported its ability to reduce NO scavenging (Bugliarello
and Sevilla, 1970; Cokelet, 1972; Butler et al., 1998; Liao et al.,
1999). Subsequently, Liao et al experimentally demonstrated its
ability to reduce NO scavenging using arteriole myography (Liao
et al., 1999). Therefore, the compartmentalization of Hb inside
the RBC and the localization of RBCs to the center of vessels
have a strong influence on vascular function by minimizing NO
scavenging.
RBC DISEASE—NO SCAVENGING
In disease, RBC membrane abnormalities promote thrombosis
(Ataga, 2009). Setty et al. showed exposure of phosphatidylserine
on RBC membranes correlates with plasma indicators of
thrombosis (Setty et al., 2001). In addition, changes to the RBC
membrane lead to RBC adhesion to the endothelium. Diseases
such as malaria, beta-thalassemia, diabetes mellitus, and sickle
cell disease show increased RBC adhesion to endothelial cells
(Kaul et al., 1989; Hovav et al., 1999; Cooke et al., 2004). Adhesion
disrupts the cell free zone, which brings RBCs and Hb closer
to the endothelium. Hoover et al. showed increased adhesion
of RBCs from sickle cell patients to endothelial cells (Hoover
et al., 1979) and Hebbel et al further demonstrated sickle RBC
adhesion and suggested the adhesion may be a pathogenic factor
in microvascular occlusion (Hebbel et al., 1980b). Hebbel also
demonstrated a correlation between erythrocyte adhesion and
sickle cell disease severity (Hebbel et al., 1980a). Kaul et al.
developed a two-stage model of RBC adhesion initiating vaso-
occlusion (Kaul et al., 1989). Thus, a role of RBC adhesion in
initiating vaso-occlusive crisis is a widely supported hypothesis
(Manwani and Frenette, 2013).
In addition to adhesion, polymerization of hemoglobin in
sickle cell disease leads to rigid, inflexible red blood cells, which
effect blood rheology. Moreover, oxygenated sickle RBC also
displays changes in cell mechanics and therefore blood rheology,
attributed to altered hemoglobin concentration in the cell and
changes to the cell membrane (Nash et al., 1984). Changes
in blood rheology affect tissue perfusion and may affect NO
production through changes in shear stress on vessel walls.
In addition to sickle cell disease, many other diseases display
altered RBC deformability. In hypertension RBC deformability
decreases, blood viscosity increases and RBCs form more stable
aggregates (Cicco and Pirrelli, 1999). These changes exacerbate
hypertension and effect oxygen transport (Cicco and Pirrelli,
1999). Diabetes and hypercholesterolemia, both risk factors
for cardiovascular disease, show abnormal RBC membrane
architecture and impaired deformability, which alter blood
rheology (Shin et al., 2005; Tomaiuolo, 2014). It is difficult
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to determine if altered RBC deformability and therefore blood
rheology are concurrent or contributing factors to the changes in
vascular function in these diseases.
Work by Bor-Kucukatay et al. suggest vascular function,
specifically nitric oxide production could play a role in
RBC deformability and rheological alterations to RBCs during
hypertension (Bor-Kucukatay et al., 2000, 2003). They suggest
NO improves RBC deformability (Bor-Kucukatay et al., 2003).
However, other labs have found that NO does not have a direct
effect on RBC deformability (Barodka et al., 2014; Belanger
et al., 2015). On the other hand, select NO donors, sodium
nitroprusside and nitrite, protect against calcium-influx induced
RBC dehydration and loss of deformability (Barodka et al.,
2014; Belanger et al., 2015; Wajih et al., 2017). Use of sodium
nitroprusside and nitrite to improve rheology in diseases affected
by poor RBC deformability would thus be worth exploring.
As reviewed above, encapsulation of Hb inside RBCs greatly
reduces its ability to scavenge NO produced by the endothelium.
However, in multiple diseases RBC hemolysis occurs introducing
cell-free Hb into the vasculature (Reiter et al., 2002; Sobolewski
et al., 2005). The pathology associated with hemoglobin-based
blood substitutes demonstrated the hypertensive effects of cell-
free Hb (Doherty et al., 1998). Additionally, there is support for
the implication of hemolysis in vaso-occlusive crisis (VOC) as
hemolytic transfusion reactions can precipitate VOC (Jang et al.,
2011; Manwani and Frenette, 2013).
Cell-free hemoglobin reactions in the vasculature and
surrounding tissues through extravasation may add to disease
conditions (Schaer et al., 2013). In vitro findings suggest cell-free
hemoglobin has the potential to release hemin and take part in
oxidative reactions resulting in oxidative stress and inflammation
(Miller et al., 1997; Jia et al., 2007; Manwani and Frenette,
2013). Patients with elevated plasma Hb show a reduction in
NO-dependent blood flow response, consistent with a decrease
in vasodilatory response to NO donor sodium nitroprusside by
patients with SCD (Rother et al., 2005).
In addition to releasing Hb, hemolysis also releases arginase,
an enzyme that converts L-arginine to ornithine, into the blood
stream. L-arginine is the substrate for nitric oxide synthesis by
eNOS and therefore, the release of arginase further diminishes
NO production and vascular function (Morris et al., 2003;
Schnog et al., 2004). Hemolysis and changes to RBC membrane
proteins in disease effect vascular function through promoting
thrombosis, initiating vascular occlusion, scavenging NO, and
oxidative stress.
Red blood cell breakdown not only decreases NO
bioavailability through NO scavenging by cell-free Hb, but also
by production of red blood cell microparticles (Donadee et al.,
2011; Liu et al., 2013). Like cell-free Hb, red cell microparticles
(on the order of 50-100 nm in diameter) scavenge NO hundreds
of times faster than Hb encapsulated in the RBC, but not quite
as fast as cell-free Hb (Donadee et al., 2011). In addition, these
particles enter the cell-free zone (Liu et al., 2013). Red cell
hemolysis and micropartcile formation have been proposed to
contribute to poor outcomes associated with transfusion of older
stored blood due to NO scavenging (Gladwin and Kim-Shapiro,
2009; Donadee et al., 2011). Substantial evidence suggests that
extravasation plays a major role in NO dysregulation, so that
proper compartmentalization of Hb is key (Kim-Shapiro and
Patel, 2016; Schaer et al., 2016).
RBC hemolysis contributes to the vascular pathology
of diseases and disorders such as thalassemia, hereditary
spherocytosis, Glucose-6-phosphate dehydrogenase deficiency,
paroxysmal nocturnal, hemoglobinuria, and autoimmune
hemolytic anemia (Johnson et al., 1979; Rother et al., 2005).
Additionally, these diseases and disorders also lead to the
increased formation of RBC microparticles (Piccin et al., 2007;
Westerman and Porter, 2016). Moreover, hemolysis is also
associated with blood transfusion, hemodialysis and cardiac
bypass surgery (Meyer et al., 2010).
PRODUCTION OF NITRIC OXIDE
In contrast to the role played by RBCs in diminishing
NO. Research shows deoxy-RBCs promote vasodilation in the
presence of nitrite (Cosby et al., 2003; Jensen and Agnisola,
2005; Crawford et al., 2006). Other mechanisms of vasodilatory
action by RBCs have been proposed. Researchers continue to
debate the mechanism or mechanisms of hypoxic vasodilation
which include: (1) ATP release by RBCs due to deoxygenation,
(2) SNO-Hb formation and S-nitrosothiol release and delivery
during oxy/deoxy hemoglobin cycling, and (3) nitrite reduction
by hemoglobin to NO.
ATP activates purinoceptors on endothelial cells leading to the
production of NO and alteration of vascular tone (Ralevic and
Burnstock, 1991). In line with the mechanism of ATP release
by RBC under hypoxia, Ellsworth et al. showed that RBCs
release more ATP under low PO2 and low pH than RBCs under
normoxia and normal pH (Ellsworth et al., 1995). Additionally,
they demonstrated intraluminal ATP increased vessel diameter
and flow rate (Ellsworth et al., 1995). Following this work,
Dietrich et al. showed perfusion of RBCs at low PO2 caused vessel
dilation and an increased concentration of ATP in the effluent
(Dietrich et al., 2000).
Addition of nitrite to deoxyRBCs showed an enhanced effect
on vasodilation when infused (Cosby et al., 2003; Jensen and
Agnisola, 2005; Crawford et al., 2006). In support of ATP release
being responsible for this enhanced dilation in the presence of
nitrite, Cao et al. measured an increased synthesis and hypoxic
release of RBC ATP in the presence of nitrite (Cao et al.,
2009). However, research showed a vasodilatory response in the
presence of nitrite and RBCs when NOS inhibitors L-NAME
and L-NMMA were used, suggesting a different mechanism of
dilation is responsible for the enhancement by nitrite (Crawford
et al., 2006; Liu et al., 2015).
The second proposed mechanism for the effect deoxyRBC
and nitrite on vascular function is the formation of SNO-Hb
in the presence of nitrite and subsequent release of NO from
deoxygenated SNO-Hb. Research has demonstrated the hypoxic
release of NO from SNO-Hb and the ability of the released NO
to relax vessels (Stamler et al., 1997; McMahon et al., 2002).
Diesen et al. showed a decrease in RBC SNO-Hb concentration
correlated with abolished vessel hypoxic dilation (Diesen et al.,
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2008). The proposed mechanism of release is a reduction in the
stability of SNO-Hb when Hb transitions from the R-state to the
T-state and work by Doctor et al. further supports the proposal
coupling SNO-Hb concentration to oxygen saturation (Doctor
et al., 2005). However, for this mechanism to be relevant in
vivo SNO-Hb must form during the oxygenation/deoxygenation
cycle of RBCs. This leads to the question of how SNO-Hb
forms. Huang et al. and Xu et al. ruled out allosterically-
controlled transfer of NO from HbNO to the beta-93 cysteine
of Hb (Xu et al., 2003; Huang et al., 2006). In addition, the
role of nitrite in the formation of a semi-stable metHb-NO
intermediate capable of SNO-Hb formation was ruled out by
Basu et al. (Angelo et al., 2006; Nagababu et al., 2006; Basu
et al., 2007). Lastly, Isbell et al. demonstrated nitrite associated
NO bioactivity in beta-93 knockout mice, demonstrating SNO-
Hb is not responsible for nitrite associated hypoxic vasodilation
(Isbell et al., 2007). While data supports the release of NO
from SNO-Hb under deoxygenated conditions, research has yet
to elucidate a physiological mechanism of SNO-Hb formation
therefore bringing to question the physiological relevance of
SNO-Hb in vascular function.
The last proposed mechanism of RBC vasodilation in the
presence of nitrite is the reduction of nitrite to NO by Hb. Brooks
first studied the nitrite Hb interaction in 1937 and this work was
later extended by Doyle in 1981 (Brooks, 1937; Doyle et al., 1981).
Nitrite reacts with deoxygenated Hb to form metHb and NO
(Brooks, 1937; Doyle et al., 1981). NO then reacts rapidly with
deoxygenated Hb, at a rate dependent on the conformation state
of the Hb (Huang et al., 2005a,b), to form HbNO. In vitro studies
have rejected a significant role in the reduction of nitrite by other
RBC molecules such as xanthine oxidoreductase and carbonic
anhydrase supporting the hypothesis that hemoglobin plays a
dominant role (Liu et al., 2015). Due to the rapid scavenging
of NO by Hb the question of how NO bioactivity escapes the
RBC still remains. However, data continues to grow in support
of NO bioactivity escaping the deoxy-RBC in the presence of
nitrite. For example, platelets activation and aggregation by ADP
is diminished in the presence of deoxyRBCs and nitrite (Srihirun
et al., 2012; Park et al., 2014; Liu et al., 2015; Wajih et al., 2016).
Platelets stimulated by ADP in the presence of nitrite alone do
not show reduced activation (Srihirun et al., 2012). The addition
of a NO scavenger to platelets stimulated by ADP in the presence
of deoxy-RBCs and nitrite abrogates the diminished activation
(Wajih et al., 2016). These data strongly support a role of RBCs
in bioactivating nitrite.
However, once NO is formed inside a RBC, it must somehow
escape rapid scavenging by the intraerythrocytic Hb. Proposed
mechanisms of escape of NO bioactivity from the RBC have
included S-nitrosothiol formation and the role of the RBC
membrane. Research by Basu et al and Roche et al suggested
S-nitrosothiol formation could occur through a metHb-nitrite
mediated N2O3 formation (Basu et al., 2007; Roche et al., 2013).
Pawloski proposed a mechanism where low molecular weight
S-nitrosothiols could transnitrosylate AE1, an abundant RBC
ion transporter, and eventually escape the RBC (Pawloski et al.,
2001). Another proposed mechanism, is an increased affinity
of metHb-NO or Hb-NO+ for the RBC membrane, which in
turn could also lead to NO escape through nitrosylation of AE1
(Salgado et al., 2015). Lastly, Wajih et al have published evidence
supporting a role of RBC membrane nitrosation in the escape
of NO bioactivity (Wajih et al., 2016). While this is a start
in determining the mechanism of NO bioactivity, much work
remains.
Other heme-globin nitrite reducers may play a role in
modulating vascular function. Deoxymyoglobin reduces nitrite
faster than Hb (Shiva et al., 2007). Nitrite reduction by
vascular smoothmuscle myoglobin has been shown to contribute
significantly to vasodilation in a murine model (Ormerod et al.,
2010). Neuroglobin and cytoglobin also have nitrite reducing
activity that is modulated by cysteine oxidation state (Tiso et al.,
2011; Li et al., 2012; Tejero et al., 2014; Amdahl et al., 2017).
Globin X from fish red blood cells reduces nitrite about 200
times faster than Hb and may represent a primordial function of
heme-globins in nitrite reduction (Corti et al., 2016).
THERAPEUTICS FOR RBC ASSOCIATED
VASCULOPATHY
The production of NO by deoxyRBCs in the presence of
nitrite and other NO donors provide a potential therapeutic
role for plasma nitrite in reducing vasoconstriction, RBC
adhesion, and potentially improving RBC deformability (Space
et al., 2000; Bor-Kucukatay et al., 2003; Lundberg et al.,
2008; Horn et al., 2011). NO administration can neutralize
the NO scavenging ability of cell-free Hb by preferentially
reacting, converting oxygenated hemoglobin to non-scavenging
methemoglobin (Reiter et al., 2002). Antioxidants aim to improve
blood rheology and vascular function through reduction of
oxidative stress, shown by researchers to exacerbate hemolysis
and endothelial dysfunction (Fibach and Rachmilewitz, 2008; den
Hartog et al., 2010). Hemin and hemoglobin scavenger proteins
also provide a potential therapeutic against damage caused by
cell free hemoglobin and hemin (Schaer et al., 2013). Lastly,
adhesion molecule inhibitors may act as a therapeutic against
RBC adhesion to the endothelium; for example, Hebbel et al.
showed adhesion molecule inhibitor HDAC reduced endothelial
activation (Hebbel et al., 2009; Vinchi and Tolosano, 2013).
A recent trial of a compound that interferes with adhesion of
neutrophils and other circulating blood cells to endothelial cells
successfully decreased the frequency of painful crises in patients
with sickle cell disease (Ataga et al., 2017).
CONCLUSIONS
Red blood cells play an important role in vascular function.
Through the compartmentalization of Hb, RBCs deliver oxygen,
minimize NO scavenging, sense oxygen tension, and deliver NO
bioactivity in hypoxia. In healthy conditions, RBCs promote
hemostasis through the well-regulated delivery of oxygen and the
balance of NO scavenging and production. As data has shown,
the RBC, once only viewed as a sink for NO, has the ability to
produce NO bioactivity under hypoxia. The important role of the
RBC in vascular function becomes more evident in diseases that
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alter or compromise the RBCmembrane leading to conditions of
oxidative stress, hypertension, thrombosis, and vaso-occlusion.
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